Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) rhizome, with
anti-oxidant/anti-inflammatory effects demonstrated in various disease models, including
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) developed an
anti-inflammatory compound C66, which prevented inflammatory diabetic complications via
3-Hydroxyimino derivatives of minor licorice triterpenoids possessed pronounced antiulcer
activityBogdanov, AV,
Sirazieva, AR,
Voloshina, AD,
Abzalilov, TA,
Abzalilov, TA,
Mironov, VF (2022) -ethylisatins showed the highest antiplatelet
activity which exceeded the
activity of acetylsalicylic acid by a
TUGUZBAEVA, G.,
YUE, E.,
CHEN, X.,
HE, L.,
LI, X.,
JU, J.,
QIN, Y.,
PAVLOV, V.,
LU, Y.,
JIA, W.,
BAI, Y.,
NIU, Y.,
YANG, B (2019) to investigate the
anti-OSCC potential of novel endostatin-derived polypeptide PEP06 as a cluster
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and antioxidant
activity revealed promising compounds